Neurology

When a patient presents to their primary care physician with a headache, it's not always diagnosed as the migraine it is. These 6 tips from a neurologist can help.

Highlights of an evidence-based review offer practical guidance for effective depression screening and assessment strategies for primary care physicians.

A new study being presented next week at AHA's 2019 Scientific Sessions found a strong link between depression and non-fatal heart disease. 

Two studies to be presented at the upcoming AHA annual meeting found that young cannabis users are at greater risk for stroke and arrhythmia. 

"Typical aura without headache" is a relatively rare headache diagnosis and not easy to make. Three leading headache specialists offer guidance on how to recognize and treat.

Lasmitidan is the first 5-HT1F receptor agonist to receive FDA approval and was found superior to placebo for reduction of migraine pain and most bothersome symptom at 2 hours.

Children, tweens, and adolescents with migraine can use Migraine Trainer to log and share details that will help physicians individualize care in this vulnerable population.

A new study suggests that deep brain stimulation may be a safe and effective treatment option for patients with treatment-resistant depression. 

Throbbing occipital headache x2 wks; abrupt onset, no history. Reason for alarm? Neurologist Peter McAllister, MD, suggests you SNOOP first.

Veterans who suffer from mental illness were found to be at an increased risk for major cardiovascular disease outcomes in a new study. 

What's your caffeine IQ? Test your knowledge on the latest caffeine research from its effect on cardiovascular disease to liver cancer with this brief quiz. 

Injectable medications for migraine are effective, inexpensive, and easy to store. Try these 5 questions on 5 you may want to have on hand.

Read why one migraine specialist believes that biofeedback should be the first line of treatment in patients with migraine. 

A cup of coffee/day keeps migraine away? It can, but before recommending another cup to migraine patients, review findings just published.

Caffeine moderation moderates cardiovascular risk, caffeine is not what is keeping you up at night, and 4 more recent studies on caffeine intake. 

When treating patients with chronic headache or migraine, assessing sleep quality can be critical, according to this specialist. 

Here: A snapshot of the 4 FDA-approved neuromodulation devices and a primer on neuromodulation for migraine at work.

Neuromodulation to treat migraine and other primary headaches is proven effective in clinical trials and may be an option for your patients looking for drug-free relief.

Mindfulness, an attention-control technique, can augment medical therapy for migraineurs, with stress reduction, relaxation, and shifting negative self judgement.

Headache diagnosis can be "a pain" all year 'round, but particularly irksome when you have summer plans. Neurologist Peter McAllister, MD, serves up some apps to help with that.

Headache specialist, Stephanie Nahas, MD, MSEd, discusses the importance of a migraine journal for both patient and physician. 

Identifying the unique symptoms and risk factors for stroke in women is key to providing effective care. Answer these 5 questions to see how much you know.

How can you help migraine patients who suffer from psychiatric conditions such as depression or anxiety? A headache expert says a simple question can make a huge impact. 

How do you help patients with migraine who ask for methods other than, or as adjuvants to, medical therapy? A headache expert offers suggestions to pass on.

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

A family physician with expertise in headache treatment makes the case for appropriate use of opioids in some patients.

Vestibular migraine may be a relatively new diagnostic entity, but a new study shows it impacts around 6 million US adults. 

Primary care clinicians may be the first to note an abnormal headache pattern that calls for referral. What do you know about these not-so-simple headaches?

Noninvasive vagus nerve stimulation may be a viable method for the treatment of acute episodic migraine, according to a new study.

The first CGRP mAb has been FDA-approved, but why should you consider this novel category for migraine prevention?